These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 6140147)
1. The effects of an experimental hepatitis on the metabolic disposition of 3-o-(+)-[14C]methylcatechin in the rat. Hackett AM; Griffiths LA Drug Metab Dispos; 1983; 11(6):602-6. PubMed ID: 6140147 [TBL] [Abstract][Full Text] [Related]
2. The metabolism and excretion of 3-O-methyl-(+)-catechin in the rat, mouse, and marmoset. Hackett AM; Griffiths LA Drug Metab Dispos; 1981; 9(1):54-9. PubMed ID: 6111433 [TBL] [Abstract][Full Text] [Related]
3. Metabolism and excretion of the liver-protective agent (+)-catechin in experimental hepatitis. Shaw IC; Hackett AM; Griffiths LA Xenobiotica; 1982 Jul; 12(7):405-16. PubMed ID: 7147991 [TBL] [Abstract][Full Text] [Related]
4. The quantitative disposition of 3-O-methyl-(+)-[U-14C]catechin in man following oral administration. Hackett AM; Griffiths LA; Wermeille M Xenobiotica; 1985 Nov; 15(11):907-14. PubMed ID: 4082631 [TBL] [Abstract][Full Text] [Related]
5. The prevention by (+)-Cyanidanol-3 of hepatitis-induced changes in the disposition of imipramine in the rat. Hackett AM; Shaw IC; Griffiths LA Biochem Pharmacol; 1984 Jul; 33(14):2179-84. PubMed ID: 6466342 [TBL] [Abstract][Full Text] [Related]
6. The metabolism and excretion of 3-palmitoyl-(+)-catechin in the rat. Hackett AM; Griffiths LA Xenobiotica; 1982 Jul; 12(7):447-56. PubMed ID: 6815903 [TBL] [Abstract][Full Text] [Related]
7. The metabolism and excretion of [14C]imipramine in an experimental hepatitis. Hackett AM; Shaw IC; Griffiths LA Xenobiotica; 1984 Jun; 14(6):491-9. PubMed ID: 6475108 [TBL] [Abstract][Full Text] [Related]
8. The disposition of 3-O-methyl-(+)-catechin in the rat and the marmoset following oral administration. Hackett AM; Griffiths LA Eur J Drug Metab Pharmacokinet; 1983; 8(1):35-42. PubMed ID: 6407839 [TBL] [Abstract][Full Text] [Related]
9. Metabolism and disposition of the dopaminergic agonist 5-hydroxy-6-methyl-2-di-n-propylaminotetralin in the rat. Koble DL; Koons JC; Fischer LJ Drug Metab Dispos; 1985; 13(3):305-11. PubMed ID: 2861988 [TBL] [Abstract][Full Text] [Related]
10. The metabolism and excretion of (+)-[14C]cyanidanol-3 in man following oral administration. Hackett AM; Griffiths LA; Broillet A; Wermeille M Xenobiotica; 1983 May; 13(5):279-86. PubMed ID: 6636824 [TBL] [Abstract][Full Text] [Related]
11. Alternative transport pathways of cholephilic 14C-hexobarbital metabolites in rats with experimental hepatitis and cholestasis. Richter E; Joeres R; Buschmann J; Zilly W Acta Hepatogastroenterol (Stuttg); 1979 Dec; 26(6):429-34. PubMed ID: 549423 [TBL] [Abstract][Full Text] [Related]
12. Metabolism and excretion of trovafloxacin, a new quinolone antibiotic, in Sprague-Dawley rats and beagle dogs. Effect of bile duct cannulation on excretion pathways. Dalvie DK; Khosla NB; Navetta KA; Brighty KE Drug Metab Dispos; 1996 Nov; 24(11):1231-40. PubMed ID: 8937858 [TBL] [Abstract][Full Text] [Related]
13. Metabolism and disposition of 3-amino-1,5-dihydro-5-methyl-1-beta-D-ribofuranosyl-1,4,5,6, 8-pentaazaacenaphthylene in the rat. Basseches PJ; Powis G Cancer Res; 1984 Sep; 44(9):3672-8. PubMed ID: 6540141 [TBL] [Abstract][Full Text] [Related]
14. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs. Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117 [TBL] [Abstract][Full Text] [Related]
15. Glucuronidation as a transient intermediate metabolic step in the elimination of (-)-carbovir. Identification of (-)-carbovir-5'-O-glucuronide in rat bile. Zimmerman CL; Iyer KR; Faudskar AL; Remmel RP Drug Metab Dispos; 1993; 21(5):902-10. PubMed ID: 7902254 [TBL] [Abstract][Full Text] [Related]
16. Absorption, distribution, metabolism, and excretion of donepezil (Aricept) after a single oral administration to Rat. Matsui K; Mishima M; Nagai Y; Yuzuriha T; Yoshimura T Drug Metab Dispos; 1999 Dec; 27(12):1406-14. PubMed ID: 10570021 [TBL] [Abstract][Full Text] [Related]
17. Metabolism of MK-499, a class III antiarrhythmic agent, in rats and dogs. Vickers S; Duncan CA; Slaughter DE; Arison BH; Greber T; Olah TV; Vyas KP Drug Metab Dispos; 1998 May; 26(5):388-95. PubMed ID: 9571219 [TBL] [Abstract][Full Text] [Related]
19. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse. Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957 [TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]